 | |||||||
| finance | |||||||
| NEWS | |||||||
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20 - 23 February 2023 EMA's human medicines committee (CHMP) recommended granting a marketing authorisation for Akeega (niraparib/abiraterone acetate) for the treatment of metastatic castration-resistant prostate cancer with BRCA 1/BRCA 2 mutations. The committee adopted a ...
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment